Geneva, May 29 -- International Clinical Trials Registry received information related to the study (KCT0012013) titled 'A Study of an Anticancer Drug to Evaluate the Treatment Effect on Brain Metastases in Patients with BRAF-Mutant Solid Tumors' on May 20.
Study Type: Interventional Study
Study Design:
Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable
Primary Sponsor: Samsung Medical Center
Condition:
Neoplasms
Intervention:
Drug : 1. Subject Screening and Enrollment
Patients who meet the study eligibility criteria will receive a full explanation of the study, and those who voluntarily provide informed consent will be enrolled.
2. Study Design
This study evaluates...